Polymerization of nonfilamentous actin into microfilaments is an important process for porcine oocyte maturation and early embryo development.
Actin is one of the major proteins in mammalian oocytes. Most developmental events are dependent on the normal distribution of filamentous (F-) actin. Polymerization of nonfilamentous (G-) actin into F-actin is important for both meiosis and mitosis. This study examined G- and F-actin distribution in pig oocytes and embryos by immunocytochemical staining and confocal microscopy. Actin protein was quantified by electrophoresis and immunoblotting. G-Actin was distributed in the whole cytoplasm of oocytes and embryos irrespective of their stages. F-Actin was distributed at the cortex of oocytes and embryos at all stages, at the joint of blastomeres in the embryos, in the cytoplasm around the germinal vesicle (GV), and in the perinuclear area of 2- to 4-cell-stage embryos. No differences in the amount of actin protein were found among oocytes and embryos. Oocytes cultured in medium with cytochalasin D (CD), an inhibitor of microfilament polymerization, underwent GV breakdown and reached metaphase I but did not proceed to metaphase II. Two- to 4-cell-stage embryos cultured in medium with CD did not develop to blastocysts. When GV-stage oocytes or 2- to 4-cell-stage embryos treated with CD for 6 h were re-cultured in media without CD, oocytes or embryos re-assembled actin filaments and underwent a meiotic maturation or blastocyst formation similar to that of controls. These results indicate that it is the polymerization of G-actin into F-actin, not actin protein synthesis, that is important for both meiosis and mitosis in pig oocytes and embryos.
Wang
W H
WH
Department of Animal Science, University of Missouri-Columbia, Columbia, Missouri 65211, USA.
Abeydeera
L R
LR
Prather
R S
RS
Day
B N
BN
D008841:Actin Cytoskeleton / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure*; D000199:Actins / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure*; D000818:Animals; D015638:Cytochalasin D / Q000494:pharmacology; D004622:Embryo, Mammalian / Q000378:metabolism / Q000648:ultrastructure; D005314:Embryonic and Fetal Development; D005260:Female; D008540:Meiosis; D009865:Oocytes / Q000187:drug effects / Q000502:physiology* / Q000648:ultrastructure; D011108:Polymers; D011247:Pregnancy; D013552:Swine
D000199:Actins; D011108:Polymers; D015638:Cytochalasin D